Industry News
Notal Vision Publishes Positive Results from Pivotal Study on AI Algorithm in Home-Based OCT System

Notal Vision has announced positive results from a pivotal study evaluating an artificial intelligen...

read more
Notal Vision Publishes Positive Results from Pivotal Study on AI Algorithm in Home-Based OCT System
February 04, 2025
Beacon Therapeutics Secures RMAT Designation for Laru-Zova Gene Therapy in XLRP Treatment

Beacon Therapeutics' laruparetigene zovaparvovec (laru-zova), a gene therapy for X-linked retinitis ...

read more
Beacon Therapeutics Secures RMAT Designation for Laru-Zova Gene Therapy in XLRP Treatment
February 03, 2025
Iantrek Announces First Commercial Cases of C.Rex Micro-Interventional System for Trabecular Outflow Enhancement

Iantrek has successfully completed the first commercial cases utilizing its C.Rex micro-intervention...

read more
Iantrek Announces First Commercial Cases of C.Rex Micro-Interventional System for Trabecular Outflow Enhancement
February 03, 2025
Vyluma Announces NMPA Acceptance of NVK002 for Pediatric Myopia in China

Vyluma has announced that the National Medical Products Administration (NMPA) of China has accepted ...

read more
Vyluma Announces NMPA Acceptance of NVK002 for Pediatric Myopia in China
January 31, 2025
AI Optics’ Sentinel Camera Receives FDA 510(k) Clearance for Portable Retinal Imaging

AI Optics, a medical device company specializing in artificial intelligence-driven ophthalmic soluti...

read more
AI Optics’ Sentinel Camera Receives FDA 510(k) Clearance for Portable Retinal Imaging
January 31, 2025
EMA Endorses Macustar's Research on Early AMD Clinical Trials

The European Medicines Agency (EMA) has issued its third Letter of Support to the Macustar consortiu...

read more
EMA Endorses Macustar's Research on Early AMD Clinical Trials
January 30, 2025
Harrow Launches "Harrow Cares" Program in Partnership with Cencora

Harrow, a leading eye care pharmaceutical company in North America, has announced the launch of Harr...

read more
Harrow Launches
January 30, 2025
SeaBeLife Reports Promising In Vivo Results for SBL03 Ophthalmic Gel in Geographic Atrophy

SeaBeLife has announced promising in vivo preclinical results for its investigational drug SBL03, an...

read more
SeaBeLife Reports Promising In Vivo Results for SBL03 Ophthalmic Gel in Geographic Atrophy
January 30, 2025
Viralgen and Axovia Therapeutics Partner to Develop Gene Therapy for Bardet-Biedl Syndrome

Viralgen and Axovia Therapeutics have announced a strategic collaboration to develop and manufacture...

read more
Viralgen and Axovia Therapeutics Partner to Develop Gene Therapy for Bardet-Biedl Syndrome
January 29, 2025
Apellis Pharmaceuticals Secures Australian Approval for Syfovre (Pegcetacoplan) in Geographic Atrophy Treatment

Apellis Pharmaceuticals has announced that the Therapeutic Goods Administration (TGA) of Australia h...

read more
Apellis Pharmaceuticals Secures Australian Approval for Syfovre (Pegcetacoplan) in Geographic Atrophy Treatment
January 29, 2025
More